日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Accuracy of a helium-beam radiography system based on thin pixel detectors for an anthropomorphic head phantom

基于薄像素探测器的氦束射线照相系统对人体头部模型的精度

Metzner, Margareta; Longarino, Friderike K; Ackermann, Benjamin; Schlechter, Annika; Saphörster, Maike; Xu, Yanting; Schlecker, Julian; Wohlfahrt, Patrick; Richter, Christian; Brons, Stephan; Debus, Jürgen; Jäkel, Oliver; Martišíková, Mária; Gehrke, Tim

Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)

BI 1015550 在进行性肺纤维化患者中的 III 期双盲、随机、安慰剂对照试验设计(FIBRONEER-ILD)

Maher, Toby M; Assassi, Shervin; Azuma, Arata; Cottin, Vincent; Hoffmann-Vold, Anna-Maria; Kreuter, Michael; Oldham, Justin M; Richeldi, Luca; Valenzuela, Claudia; Wijsenbeek, Marlies S; Coeck, Carl; Schlecker, Christina; Voss, Florian; Wachtlin, Daniel; Martinez, Fernando J

Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates: Findings From In Vitro Analyses and an Open-Label, Single-Sequence Phase I Study

新型甘氨酸转运蛋白1抑制剂BI 425809与细胞色素P450和P-糖蛋白底物的药代动力学相互作用:体外分析和一项开放标签、单序列I期研究的结果

Desch, Michael; Schlecker, Christina; Hohl, Kathrin; Liesenfeld, Karl-Heinz; Chan, Tom; Müller, Fabian; Wunderlich, Glen; Keller, Sascha; Ishiguro, Naoki; Wind, Sven

Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis

BI 1015550(一种优先磷酸二酯酶 4B 抑制剂)在健康男性和特发性肺纤维化患者中的 I 期研究

Maher, Toby M; Schlecker, Christina; Luedtke, Doreen; Bossert, Sebastian; Zoz, Donald F; Schultz, Armin

The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [(14)C]-BI 425809 in Healthy Males

健康男性口服 BI 425809 或口服联合静脉注射微量示踪剂 [(14)C]-BI 425809 后,其绝对生物利用度、吸收、分布、代谢和排泄情况

Burkard, Ute; Desch, Michael; Shatillo, Yury; Wunderlich, Glen; Mack, Salome Rebecca; Schlecker, Christina; Teitelbaum, Aaron M; Liu, Pingrong; Chan, Tom S

Mechanisms and potential immune tradeoffs of accelerated coral growth induced by microfragmentation

微碎片化诱导珊瑚加速生长的机制及潜在的免疫权衡

Schlecker, Louis; Page, Christopher; Matz, Mikhail; Wright, Rachel M

Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies

新型GlyT1抑制剂BI 425809的药代动力学和药效学评价:转化研究

Rosenbrock, Holger; Desch, Michael; Kleiner, Oliver; Dorner-Ciossek, Cornelia; Schmid, Bernhard; Keller, Sascha; Schlecker, Christina; Moschetti, Viktoria; Goetz, Sophia; Liesenfeld, Karl-Heinz; Fillon, Gwenaelle; Giovannini, Riccardo; Ramael, Steven; Wunderlich, Glen; Wind, Sven

Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics

在年轻和老年健康志愿者中多次递增剂量口服 BI 425809(一种 GlyT1 抑制剂):一项随机、双盲、I 期研究,旨在调查其安全性和药代动力学

Moschetti, Viktoria; Schlecker, Christina; Wind, Sven; Goetz, Sophia; Schmitt, Holger; Schultz, Armin; Liesenfeld, Karl-Heinz; Wunderlich, Glen; Desch, Michael

Corrigendum: Incorrect Spelling of Author's Name: US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses

更正:作者姓名拼写错误:美国预防服务工作组前列腺特异性抗原筛查指南导致格里森评分诊断结果偏高

Gejerman, Glen; Ciccone, Patrick; Goldstein, Martin; Lanteri, Vincent; Schlecker, Burton; Sanzone, John; Esposito, Michael; Rome, Sergey; Ciccone, Michael; Margolis, Eric; Simon, Robert; Guo, Yijun; Pentakota, Sri-Ram; Sadeghi-Nejad, Hossein

US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses

美国预防服务工作组前列腺特异性抗原筛查指南导致格里森评分诊断率升高

Gejerman, Glen; Ciccone, Patrick; Goldstein, Martin; Lanteri, Vincent; Schlecker, Burton; Sanzone, John; Esposito, Michael; Rome, Sergey; Ciccone, Michael; Margolis, Eric; Simon, Robert; Guo, Yijun; Pentakota, Sri-Ram; Sadeghi-Nejad, Hossein